Table of Contents

Attention Deficit Hyperactivity Disorder (ADHD) is commonly perceived as a childhood condition, yet research demonstrates that it frequently persists into adulthood, affecting millions of individuals worldwide. In about two-thirds of the cases, ADHD symptoms persist into adulthood and often cause significant functional impairment. Understanding the multifaceted causes of ADHD in adults is essential for developing effective management strategies, reducing stigma, and providing appropriate support. This comprehensive article explores the complex interplay of genetic, neurobiological, and environmental factors that contribute to ADHD in adults, offering insights into the latest research and clinical understanding of this neurodevelopmental disorder.

What is ADHD in Adults?

ADHD is a neurodevelopmental disorder characterized by persistent patterns of inattention, hyperactivity, and impulsivity that interfere with daily functioning and development. While symptoms often begin in childhood, many adults continue to experience significant challenges related to executive function, emotional regulation, and attention control. Adult ADHD can manifest differently than childhood ADHD, with hyperactivity often presenting as inner restlessness and difficulty relaxing rather than overt physical activity.

The disorder affects various aspects of adult life, including work performance, relationships, time management, and overall quality of life. Adults with ADHD may struggle with organization, meeting deadlines, maintaining focus during conversations, and managing impulsive behaviors. Understanding the underlying causes of these symptoms is crucial for both individuals living with ADHD and healthcare providers working to support them.

The Genetic Foundation of ADHD

Genetics plays a profound role in the development of ADHD, making it one of the most heritable psychiatric conditions known to science. Research consistently demonstrates that ADHD runs in families, with genetic factors accounting for a substantial portion of the risk for developing the disorder.

Heritability Rates and Family Studies

A large proportion of ADHD risk can be explained by genetics, with an estimated twin heritability of 77–88%. This remarkably high heritability rate places ADHD among the most genetically influenced psychiatric disorders, similar to that of autism spectrum disorder (about 80%), bipolar disorder (about 75%), and schizophrenia (about 80%).

Family studies provide compelling evidence for the genetic basis of ADHD. Research shows that if you have a sibling with ADHD, you're about nine times more likely to develop it yourself. Additionally, 40% of parents with ADHD have children who also meet the diagnostic criteria. These statistics underscore the strong familial clustering of ADHD and highlight the importance of considering family history when evaluating individuals for the disorder.

Adoption studies suggest that the familial factors of ADHD are attributable to genetic factors rather than shared environmental factors, with biological relatives of children with ADHD showing higher rates of the disorder than adoptive relatives. This finding helps distinguish genetic influences from environmental factors that might be shared within families.

Common Genetic Variants and Polygenic Risk

The genetic architecture of ADHD is highly complex, involving numerous genes that each contribute small effects. Large genome-wide association studies (GWASs) have found that common genetic variants explain 14–22% of the overall variation in liability. The most recent GWAS of ADHD identified 27 genome-wide significant loci and estimated that around 7,300 common variants explain 90% of the single-nucleotide polymorphism (SNP) heritability of ADHD.

This discrepancy between the high heritability observed in twin studies (77-88%) and the lower proportion explained by common genetic variants (14-22%) is often referred to as "missing heritability." Researchers believe this gap may be explained by several factors, including rare genetic variants, gene-environment interactions, epigenetic mechanisms, and structural variations in DNA that are not captured by standard genetic studies.

Rare Genetic Variants and Specific Risk Genes

Recent research has identified rare genetic variants that confer higher individual risk for ADHD. An analysis of rare genetic variants identifies three genes—MAP1A, ANO8 and ANK2—that have a role in attention deficit hyperactivity disorder (ADHD), providing insights into specific biological mechanisms underlying the disorder.

Additionally, four genes putatively causal for ADHD in cortical tissues (fetal: ST3GAL3, PTPRF, PIDD1; adult: ST3GAL3, TIE1) have been identified through advanced genetic analysis techniques. These discoveries help researchers understand how genetic variations affect brain development and function at different life stages.

Many of the genes associated with ADHD are involved in dopamine regulation, a neurotransmitter system critical for attention, motivation, and reward processing. Several studies have identified that variants in genes such as the dopamine-transporter gene DAT1, the dopamine-receptor genes DRD4 and DRD5, and genes encoding serotonin transporters (5HTT) and receptors (HTR1B), could be important for the symptoms of people with ADHD.

These genetic findings align with neurobiological research showing alterations in dopamine systems in individuals with ADHD, creating a coherent picture of how genetic variations may translate into the symptoms experienced by those with the disorder.

Brain Structure and Function in ADHD

Neuroimaging studies have revealed consistent differences in brain structure, function, and connectivity between individuals with ADHD and those without the disorder. These neurobiological differences help explain the cognitive and behavioral symptoms associated with ADHD and provide targets for therapeutic intervention.

Structural Brain Differences

Research has identified several key structural differences in the brains of individuals with ADHD. The structure of the ADHD brain can also differ from a non-ADHD brain in certain areas, including the frontal cortex, which regulates your behavior, emotions, and attention. The prefrontal cortex, in particular, shows reduced volume in many individuals with ADHD, which correlates with difficulties in executive functions such as planning, working memory, and impulse control.

The limbic system influences your emotions and motivation. ADHD-related changes to this area of the brain can contribute to hyperactivity, inattention, and poorer decision-making. The basal ganglia, another critical brain region involved in motor control and habit formation, also shows structural differences in ADHD.

Patients with ADHD, who had significant loss of grey matter in the brain, as measured by magnetic resonance imaging, showed significant impairments in attentional performance compared with healthy individuals. These structural changes are not merely correlational but appear to have functional consequences for cognitive performance and symptom severity.

Functional Connectivity and Brain Networks

Beyond structural differences, ADHD is associated with altered patterns of functional connectivity—the way different brain regions communicate and work together. ADHD may alter the network connections between your prefrontal cortex (a section of the frontal lobe) and other areas of the brain. Scientists believe this is associated with poor planning, distractability, impulsivity, and forgetfulness in ADHD.

Other deficits in networks of the frontal and parietal lobes of the brain can affect your attention, motivation, and ability to control your responses and predict the difficulty of a task. It may also change how you make decisions based on the perceived rewards. These network-level disruptions help explain why ADHD affects such a wide range of cognitive functions rather than just a single domain.

The default mode network (DMN), which is active during rest and internal thought processes, shows altered activity patterns in ADHD. This may contribute to difficulties with mind-wandering, maintaining focus on external tasks, and transitioning between different mental states.

Executive Function Impairments

Many of the brain differences observed in ADHD directly impact executive functions—the cognitive processes that enable goal-directed behavior. Executive functions include working memory, cognitive flexibility, inhibitory control, planning, and organization. Adults with ADHD often experience significant challenges in these areas, affecting their ability to manage complex tasks, regulate emotions, and adapt to changing situations.

Working memory deficits, in particular, are common in ADHD and relate to difficulties holding information in mind while performing mental operations. This can manifest as forgetting instructions, losing track of conversations, or struggling to follow multi-step processes. These executive function impairments have a neurobiological basis in the structural and functional brain differences discussed above.

Neurotransmitter Systems and Brain Chemistry

The neurochemical basis of ADHD has been a focus of research for decades, with particular attention to neurotransmitter systems that regulate attention, motivation, and impulse control. Understanding these chemical imbalances provides insight into both the causes of ADHD symptoms and the mechanisms by which treatments work.

The Dopamine Hypothesis

Dopamine dysfunction has long been implicated in ADHD, though the exact nature of this dysfunction continues to be refined through ongoing research. The dopamine hypothesis refers to reduced synthesis, content, metabolism and rate of extracellular accumulation of the dopamine neurotransmitter within frontostriatal regions in people with ADHD.

Experts believe that lower levels of dopamine and norepinephrine are both linked to ADHD. An imbalance in the transmission of dopamine in the brain may be associated with symptoms of ADHD, including inattention and impulsivity. This dopamine dysregulation also affects the reward pathway, changing how the ADHD brain perceives reward and pleasure.

Research using positron emission tomography (PET) imaging has provided direct evidence of dopamine system alterations in ADHD. Regions showed significantly lower dopamine D2/D3 receptor availability in participants with attention-deficit/hyperactivity disorder (ADHD) than in controls. Regions showed significantly lower dopamine transporter availability in the participants with ADHD than in controls. These findings suggest that both dopamine receptors and transporters are affected in ADHD.

Dopamine Transporters and ADHD

Scientists believe that these disruptions could be due to an unusual number of dopamine transporters in the brains of people with ADHD. A dopamine transporter is a protein that is responsible for removing dopamine from the gap between neurons and terminating dopamine transmission. An increased number of these transporters can lead to unusually low amounts of dopamine in the brain.

This mechanism helps explain why stimulant medications are effective for many people with ADHD. Stimulant medications such as Adderall are often successful in reducing ADHD symptoms, and these medications suppress the reuptake, or removal, of dopamine. By blocking dopamine transporters, these medications increase the availability of dopamine in the synapse, improving attention and reducing impulsivity.

However, it's important to note that these findings question the previously accepted view that major abnormalities in dopamine function are the main cause of ADHD in adult patients. While the results show that Ritalin has a 'therapeutic' effect to improve performance, it does not appear to be related to fundamental underlying impairments in the dopamine system in ADHD. This suggests that while dopamine plays an important role, ADHD is not simply a "dopamine deficiency disorder."

Norepinephrine and Other Neurotransmitters

One of the most significant differences between an ADHD brain vs. a normal brain is the level of norepinephrine (a neurotransmitter). Norepinephrine is synthesized from dopamine. Noradrenaline plays an important role in the prefrontal cortex, and ADHD may disrupt its transmission in the brain.

Reduced levels of the neurotransmitters serotonin and norepinephrine may also contribute to the development of ADHD. This multi-neurotransmitter perspective recognizes that ADHD involves complex interactions among several chemical messenger systems, not just dopamine alone. Different neurotransmitter systems may contribute to different symptom domains, which could explain the heterogeneity of ADHD presentations and treatment responses.

Reward Processing and Motivation

The dopamine system plays a crucial role in reward processing and motivation, areas where individuals with ADHD often experience difficulties. In ADHD, there might be lower levels of dopamine in the brain. This makes it harder to maintain motivation, especially when the rewards seem small or not immediate. ADHD brains tend to favor short-term, smaller rewards over long-term, more significant ones.

This altered reward processing has significant implications for daily functioning. Adults with ADHD may struggle with tasks that don't provide immediate gratification, have difficulty maintaining long-term goals, and experience challenges with delayed rewards. Understanding this neurobiological basis can help individuals with ADHD and their support systems develop strategies that work with, rather than against, their brain's reward system.

Environmental Factors and ADHD Risk

While genetics and neurobiology play substantial roles in ADHD, environmental factors also contribute to the development and expression of the disorder. Both genetic and environmental factors can influence your likelihood of having ADHD. Understanding these environmental influences is important for prevention efforts and for recognizing that ADHD arises from a complex interplay of multiple factors.

Prenatal and Perinatal Factors

Exposure to certain substances and conditions during pregnancy can increase the risk of ADHD in offspring. Maternal smoking during pregnancy has been consistently associated with increased ADHD risk, likely due to nicotine's effects on developing dopamine systems in the fetal brain. Similarly, prenatal alcohol exposure can disrupt normal brain development and increase the likelihood of attention and behavioral problems.

Other prenatal factors that may contribute to ADHD risk include maternal stress, nutritional deficiencies, and exposure to environmental toxins such as lead and certain pesticides. Complications during pregnancy and birth, including premature birth and low birth weight, have also been associated with higher rates of ADHD, though these factors typically interact with genetic vulnerability rather than causing ADHD independently.

Early Childhood Experiences

Adverse childhood experiences, including trauma, neglect, and chronic stress, can impact brain development and contribute to ADHD symptoms. While these experiences do not directly cause ADHD in the same way that genetic factors do, they can exacerbate symptoms, affect the severity of the disorder, and complicate treatment.

The developing brain is particularly sensitive to environmental influences during early childhood. Chronic stress can affect the development of brain regions involved in attention and executive function, potentially contributing to ADHD-like symptoms. It's important to note, however, that ADHD is not caused by poor parenting, family problems, poor teachers or schools, too much TV, food allergies or excess sugar. These common misconceptions can lead to inappropriate blame and stigma.

Socioeconomic Factors

Lower socioeconomic status has been associated with higher rates of ADHD diagnosis, though the relationship is complex. Socioeconomic factors may influence ADHD through multiple pathways, including increased exposure to environmental toxins, higher levels of chronic stress, reduced access to healthcare and early intervention services, and nutritional factors.

It's important to recognize that socioeconomic factors don't cause ADHD directly but may interact with genetic vulnerability and affect the expression and recognition of symptoms. Additionally, having ADHD can contribute to socioeconomic challenges, creating a bidirectional relationship between the disorder and social circumstances.

Gene-Environment Interactions

The heritability that cannot be explained by main effects of rare or common variants is likely due to gene−gene interactions, gene−environment interactions or gene−environment correlations. This means that genetic and environmental factors don't operate independently but interact in complex ways to influence ADHD risk and symptom expression.

For example, individuals with certain genetic variants may be more susceptible to environmental risk factors, while protective environmental factors might mitigate genetic risk. Environmental risk factors likely work through epigenetic mechanisms, which can alter gene expression without changing the underlying DNA sequence. This emerging area of research highlights the dynamic interplay between nature and nurture in ADHD.

ADHD Across the Lifespan: Developmental Considerations

Understanding ADHD in adults requires recognizing how the disorder changes and persists across development. While ADHD symptoms often begin in childhood, the way they manifest and their impact on functioning can shift significantly as individuals mature.

Genetic Continuity and Change

The reviewed longitudinal twin studies suggest that stability in ADHD is largely due to genetic factors. In addition, longitudinal studies also provide evidence that new genetic effects for ADHD come online at different developmental stages and that these genetic factors are partly independent of those contributing to baseline symptoms.

This finding suggests that the genetic architecture of ADHD is not static but involves different genes becoming active at different life stages. Emerging evidence suggest that the genes implicated in the onset of childhood ADHD are in part distinct from those associated with the developmental course of ADHD. This developmental perspective helps explain why some individuals experience changes in symptom severity or presentation as they age.

Heritability Across Ages

Research on ADHD heritability across different age groups has yielded interesting findings. One study using cross-informant data in adults (combined parent and self-ratings) and two studies using register based clinical diagnoses in twin and family data reported the heritability of ADHD in adults to be 70–80%.

The reviewed cross-sectional studies suggest that the reported lower heritability of ADHD in adults is likely to be at least partly explained by the switch from relying one rater (parent/teacher) in childhood, to relying on self-ratings (where each twin rates themselves) of ADHD symptoms in adulthood. When rater effects are addressed using cross-informant data or clinical diagnoses, the heritability of ADHD in adulthood appears to be comparable to the heritability of ADHD in childhood.

Adult-Specific Manifestations

ADHD in adults often presents differently than in children. While hyperactivity may decrease with age, inattention and executive function difficulties often persist or become more problematic as life demands increase. Adults with ADHD may struggle with time management, organization, maintaining employment, managing finances, and sustaining relationships—challenges that reflect the same underlying neurobiological differences but manifest in age-appropriate contexts.

The persistence of ADHD into adulthood underscores the chronic nature of the disorder and the importance of understanding its biological basis. Recognizing ADHD as a neurodevelopmental condition with genetic and neurobiological roots helps combat stigma and supports the need for ongoing treatment and accommodation throughout the lifespan.

Co-Occurring Conditions and Shared Genetic Risk

There is a high prevalence of co-occurring conditions with ADHD. Common co-occurring conditions include anxiety, depression, and bipolar disorder. Understanding the genetic and neurobiological overlap between ADHD and other conditions provides insight into why these disorders frequently occur together.

Genetic Overlap with Other Disorders

Genome-wide association studies have identified variants shared between ADHD and co-occurring psychiatric disorders; however, the genetic mechanisms are not fully understood. Research has shown genetic correlations between ADHD and conditions such as autism spectrum disorder, depression, anxiety disorders, and substance use disorders.

It delivers evidence for the genetic interplay between co-occurring conditions, both previously studied and unstudied, with ADHD. This genetic overlap may explain why individuals with ADHD are at higher risk for developing other psychiatric conditions and why treatment approaches sometimes need to address multiple disorders simultaneously.

Implications for Treatment

The presence of co-occurring conditions can complicate ADHD diagnosis and treatment. Understanding the shared genetic and neurobiological mechanisms can help clinicians develop more comprehensive treatment plans that address the full spectrum of an individual's symptoms. This may involve combining different therapeutic approaches, medications, or lifestyle interventions tailored to the specific constellation of conditions present.

Clinical Implications and Future Directions

Understanding the causes of ADHD has important implications for diagnosis, treatment, and support of individuals with the disorder. As research continues to uncover the genetic, neurobiological, and environmental factors involved in ADHD, clinical practice evolves to incorporate these insights.

Personalized Medicine Approaches

The growing understanding of ADHD's genetic basis opens possibilities for more personalized treatment approaches. Polygenic risk scores, which aggregate information from multiple genetic variants, may eventually help predict treatment response and guide medication selection. However, these approaches are still in development and not yet ready for routine clinical use.

Understanding an individual's specific genetic profile, brain structure, and environmental history could theoretically allow for more targeted interventions. For example, knowing which neurotransmitter systems are most affected might guide medication choices, while understanding specific executive function deficits could inform behavioral therapy approaches.

Reducing Stigma Through Biological Understanding

Recognizing ADHD as a neurodevelopmental disorder with clear genetic and neurobiological underpinnings helps combat harmful misconceptions and stigma. ADHD is not caused by poor parenting, nutrition, stress, or video games. Understanding that ADHD involves real differences in brain structure, function, and chemistry validates the experiences of individuals with the disorder and supports the need for appropriate treatment and accommodation.

Scientists have found unique differences in the structure, chemistry, and networks of the ADHD brain. These differences can explain many of the symptoms and challenges ADHDers experience. This biological understanding doesn't diminish personal agency or the importance of behavioral strategies but provides a foundation for compassionate, evidence-based support.

Ongoing Research Priorities

Despite significant advances, many questions about ADHD remain unanswered. Because ADHD has an early age of onset, most of this work has focused on children, meaning that less is known about the genetics of ADHD in adults. Future research needs to focus more specifically on adult ADHD to understand how the disorder manifests and persists across the lifespan.

Other research priorities include better understanding the "missing heritability," identifying additional rare variants with large effects, elucidating gene-environment interactions, and developing biomarkers that could aid in diagnosis and treatment monitoring. Advances in neuroimaging, genetics, and computational modeling continue to provide new tools for investigating these questions.

Integrative Treatment Approaches

Understanding the multifaceted causes of ADHD supports the use of comprehensive, multimodal treatment approaches. Effective management typically involves a combination of medication, behavioral therapy, lifestyle modifications, and environmental accommodations. Recognizing that ADHD has biological roots doesn't mean that only biological treatments are needed; rather, the most effective approaches address the disorder at multiple levels.

Medications can help normalize neurotransmitter function, cognitive-behavioral therapy can teach compensatory strategies and address co-occurring conditions, lifestyle changes such as exercise and sleep optimization can support brain health, and environmental modifications can reduce demands on impaired executive functions. This integrative approach recognizes the complex, multifactorial nature of ADHD.

Practical Implications for Adults with ADHD

Understanding the causes of ADHD isn't just an academic exercise—it has practical implications for adults living with the disorder and those who support them.

Self-Understanding and Acceptance

Learning about the neurobiological basis of ADHD can help adults understand their lifelong struggles in a new light. Many adults with ADHD have spent years blaming themselves for difficulties with organization, time management, or emotional regulation. Understanding that these challenges stem from differences in brain structure and function can reduce self-blame and support self-acceptance.

Many people find out they have ADHD well into adulthood, as a result of their child being diagnosed. This discovery can be life-changing, reframing past challenges as part of your unique ADHD journey. This reframing can be profoundly validating and open doors to appropriate treatment and support.

Family Planning Considerations

Given the high heritability of ADHD, adults with the disorder may want to be aware of the increased likelihood that their children could also have ADHD. This knowledge can support early identification and intervention if needed, rather than causing alarm. Understanding the genetic component can also help families recognize that ADHD in children is not a result of parenting failures but a neurodevelopmental condition that benefits from appropriate support.

Workplace and Educational Accommodations

Recognizing ADHD as a neurodevelopmental disorder with biological underpinnings supports the legitimacy of workplace and educational accommodations. Adults with ADHD may benefit from modifications such as flexible work schedules, written instructions, organizational support, and reduced distractions. Understanding the neurobiological basis of these needs can help both individuals with ADHD and their employers or educators recognize accommodations as necessary supports rather than special favors.

Debunking Common Myths About ADHD Causes

Despite growing scientific understanding, many myths about ADHD causes persist. Addressing these misconceptions is important for reducing stigma and ensuring individuals receive appropriate support.

Myth: ADHD is Caused by Poor Parenting

This harmful myth has been thoroughly debunked by research. ADHD is caused by biological and genetic factors that influence neurotransmitter activity in certain parts of the brain. While parenting approaches can affect how ADHD symptoms are managed and how children with ADHD develop coping skills, parenting does not cause the underlying disorder. This distinction is crucial for reducing parental guilt and ensuring families receive support rather than blame.

Myth: ADHD is Just a Lack of Willpower

The neurobiological evidence clearly demonstrates that ADHD involves real differences in brain structure, function, and chemistry. Difficulties with attention, impulse control, and executive function are not character flaws or failures of willpower but reflect underlying neurobiological differences. Understanding this can help individuals with ADHD and those around them approach challenges with compassion rather than judgment.

Myth: Diet and Sugar Cause ADHD

While nutrition can affect overall health and potentially influence symptom severity in some individuals, diet does not cause ADHD. The disorder has clear genetic and neurobiological roots that cannot be attributed to dietary factors. That said, some individuals with ADHD may find that certain dietary approaches help them manage symptoms, but this is different from diet causing the disorder.

Myth: ADHD is Overdiagnosed and Not a Real Disorder

The extensive genetic and neurobiological research on ADHD provides compelling evidence that it is a real neurodevelopmental disorder with measurable differences in brain structure and function. While diagnostic practices may vary and some individuals may be misdiagnosed, the existence of ADHD as a legitimate medical condition is well-established in the scientific literature. The high heritability, consistent neurobiological findings, and response to treatment all support ADHD as a valid diagnostic entity.

Resources and Support for Adults with ADHD

Understanding the causes of ADHD is an important first step, but adults with the disorder also need access to appropriate resources and support. Numerous organizations provide evidence-based information, support groups, and advocacy for individuals with ADHD.

The Attention Deficit Disorder Association (ADDA) offers resources specifically for adults with ADHD, including educational materials, support groups, and connections to healthcare providers. Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD) provides comprehensive information about ADHD across the lifespan, advocacy efforts, and local support groups.

Professional organizations such as the American Psychiatric Association and the American Academy of Child and Adolescent Psychiatry offer clinical guidelines and resources for healthcare providers working with ADHD patients. The National Institute of Mental Health provides up-to-date research information and educational materials about ADHD.

Conclusion: A Comprehensive Understanding of ADHD Causes

ADHD in adults is a complex neurodevelopmental disorder arising from the interplay of genetic, neurobiological, and environmental factors. ADHD has a heritability of 74% with approximately a third of this heritability coming from common variants (e.g., single nucleotide polymorphisms [SNPs]) with small individual effect sizes. This high genetic component, combined with identifiable differences in brain structure, function, and neurotransmitter systems, provides a solid foundation for understanding ADHD as a legitimate medical condition.

The neurobiological differences observed in ADHD—including structural variations in the prefrontal cortex and limbic system, altered functional connectivity, and dysregulation of dopamine and norepinephrine systems—help explain the cognitive and behavioral symptoms experienced by individuals with the disorder. These differences are not character flaws or failures of willpower but reflect real variations in how the brain develops and functions.

Environmental factors, while not primary causes of ADHD, can influence risk and symptom expression through complex interactions with genetic vulnerability. Understanding these gene-environment interactions highlights the multifactorial nature of ADHD and the importance of comprehensive approaches to prevention and treatment.

As research continues to advance, our understanding of ADHD becomes increasingly sophisticated. New genetic discoveries, refined neuroimaging techniques, and improved understanding of neurotransmitter systems continue to shed light on the mechanisms underlying ADHD. This growing knowledge base supports the development of more targeted, personalized interventions and helps reduce stigma by grounding ADHD in biological reality.

For adults living with ADHD, understanding the causes of their condition can be empowering. It validates their experiences, reduces self-blame, and supports the pursuit of appropriate treatment and accommodations. For healthcare providers, this knowledge enables more effective, evidence-based care that addresses the full complexity of the disorder.

Ultimately, recognizing ADHD as a neurodevelopmental disorder with clear genetic and neurobiological underpinnings doesn't diminish the importance of behavioral strategies, environmental modifications, or personal agency. Rather, it provides a foundation for compassionate, comprehensive support that acknowledges both the challenges and strengths of individuals with ADHD. By continuing to advance our understanding of ADHD causes, we can improve outcomes and quality of life for the millions of adults affected by this condition.